Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $203.8 million.

  • Macrogenics' Total Liabilities rose 4108.4% to $203.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $203.8 million, marking a year-over-year increase of 4108.4%. This contributed to the annual value of $145.6 million for FY2024, which is 14.2% down from last year.
  • Macrogenics' Total Liabilities amounted to $203.8 million in Q3 2025, which was up 4108.4% from $198.8 million recorded in Q2 2025.
  • In the past 5 years, Macrogenics' Total Liabilities registered a high of $234.2 million during Q1 2023, and its lowest value of $72.4 million during Q3 2022.
  • Its 5-year average for Total Liabilities is $134.3 million, with a median of $142.1 million in 2024.
  • In the last 5 years, Macrogenics' Total Liabilities soared by 15123.62% in 2023 and then crashed by 3931.99% in 2024.
  • Over the past 5 years, Macrogenics' Total Liabilities (Quarter) stood at $95.6 million in 2021, then soared by 44.79% to $138.5 million in 2022, then grew by 5.31% to $145.8 million in 2023, then dropped by 0.14% to $145.6 million in 2024, then soared by 39.95% to $203.8 million in 2025.
  • Its Total Liabilities was $203.8 million in Q3 2025, compared to $198.8 million in Q2 2025 and $145.4 million in Q1 2025.